{"count": 10, "results": [{"_id": "36909840", "pmid": 36909840, "pmcid": "PMC10004643", "title": "Chest pain and Raynaud's phenomenon after COVID-19 vaccination in a patient previously diagnosed with systemic lupus erythematosus: a case report", "journal": "Eur Heart J Case Rep", "authors": ["Kawano H", "Umeda M", "Okano S", "Kudo T"], "date": "2023-02-24T00:00:00Z", "doi": "10.1093/ehjcr/ytad102", "meta_date_publication": "2023 Mar", "meta_volume": "7", "meta_issue": "3", "meta_pages": "ytad102", "score": 50249.13, "text_hl": "After the dose of @CHEMICAL_Azathioprine @CHEMICAL_MESH:D001379 @@@azathioprine@@@ was increased from 25 to 50 mg/day along with increased @CHEMICAL_Prednisolone @CHEMICAL_MESH:D011239 @@@prednisolone@@@ dose (10 mg/day), we added @CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@aspirin@@@ and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ (5 mg/day) for @DISEASE_Coronary_Disease @DISEASE_MESH:D003327 @@@coronary microvascular dysfunction@@@ and @<m>DISEASE_Raynaud_Disease</m> @DISEASE_MESH:D011928 @@@Raynaud's phenomenon@@@. ", "citations": {"NLM": "Kawano H, Umeda M, Okano S, Kudo T. Chest pain and Raynaud's phenomenon after COVID-19 vaccination in a patient previously diagnosed with systemic lupus erythematosus: a case report Eur Heart J Case Rep. 2023 Mar;7(3):ytad102. PMID: 36909840", "BibTeX": "@article{36909840, title={Chest pain and Raynaud's phenomenon after COVID-19 vaccination in a patient previously diagnosed with systemic lupus erythematosus: a case report}, author={Kawano H and Umeda M and Okano S and Kudo T}, journal={Eur Heart J Case Rep}, volume={7}, number={3}, pages={ytad102}}"}}, {"_id": "36653045", "pmid": 36653045, "title": "Silica associated systemic sclerosis: an occupational health hazard.", "journal": "BMJ Case Rep", "authors": ["Shivakumar DS", "Kamath NS", "Naik A"], "date": "2023-01-17T00:00:00Z", "doi": "10.1136/bcr-2022-253952", "meta_date_publication": "2023 Jan 17", "meta_volume": "16", "meta_issue": "1", "meta_pages": "", "score": 50245.34, "text_hl": "@CHEMICAL_Tadalafil @CHEMICAL_MESH:D000068581 @@@Tadalafil@@@ and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ were given for his @DISEASE_Pulmonary_Arterial_Hypertension @DISEASE_MESH:D000081029 @@@pulmonary artery hypertension@@@ and @<m>DISEASE_Raynaud_Disease</m> @DISEASE_MESH:D011928 @@@Raynaud's phenomenon@@@, respectively. ", "citations": {"NLM": "Shivakumar DS, Kamath NS, Naik A. Silica associated systemic sclerosis: an occupational health hazard. BMJ Case Rep. 2023 Jan 17;16(1):. PMID: 36653045", "BibTeX": "@article{36653045, title={Silica associated systemic sclerosis: an occupational health hazard.}, author={Shivakumar DS and Kamath NS and Naik A}, journal={BMJ Case Rep}, volume={16}, number={1}}"}}, {"_id": "34131653", "pmid": 34131653, "pmcid": "PMC8170563", "title": "Emerging treatments for scleroderma/systemic sclerosis", "journal": "Fac Rev", "authors": ["Zhu JL", "Black SM", "Chen HW", "Jacobe HT"], "date": "2021-05-05T00:00:00Z", "doi": "10.12703/r/10-43", "meta_date_publication": "2021", "meta_volume": "10", "meta_issue": "", "meta_pages": "43", "score": 50241.062, "text_hl": "Mouth augmentation and oral stretching exercises are recommended for @SPECIES_9606 @@@patients@@@ with reduced oral aperture. @<m>DISEASE_Raynaud_Disease</m> @DISEASE_MESH:D011928 @@@Raynaud's phenomenon@@@ is treated with a combination of lifestyle modification and calcium channel blockers, such as @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@. ", "citations": {"NLM": "Zhu JL, Black SM, Chen HW, Jacobe HT. Emerging treatments for scleroderma/systemic sclerosis Fac Rev. 2021;10():43. PMID: 34131653", "BibTeX": "@article{34131653, title={Emerging treatments for scleroderma/systemic sclerosis}, author={Zhu JL and Black SM and Chen HW and Jacobe HT}, journal={Fac Rev}, volume={10}, pages={43}}"}}, {"_id": "8508292", "pmid": 8508292, "title": "Amlodipine in the treatment of Raynaud's phenomenon.", "journal": "Br J Rheumatol", "authors": ["La Civita L", "Pitaro N", "Rossi M", "Gambini I", "Giuggioli D", "Cini G", "Ferri C"], "date": "1993-06-01T00:00:00Z", "doi": "10.1093/rheumatology/32.6.524-a", "meta_date_publication": "1993 Jun", "meta_volume": "32", "meta_issue": "6", "meta_pages": "524-5", "score": 50101.31, "text_hl": "@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ in the treatment of @<m>DISEASE_Raynaud_Disease</m> @DISEASE_MESH:D011928 @@@Raynaud's phenomenon@@@.", "citations": {"NLM": "La Civita L, Pitaro N, Rossi M, Gambini I, Giuggioli D, Cini G, Ferri C. Amlodipine in the treatment of Raynaud's phenomenon. Br J Rheumatol. 1993 Jun;32(6):524-5. PMID: 8508292", "BibTeX": "@article{8508292, title={Amlodipine in the treatment of Raynaud's phenomenon.}, author={La Civita L and Pitaro N and Rossi M and Gambini I and Giuggioli D and Cini G and Ferri C}, journal={Br J Rheumatol}, volume={32}, number={6}, pages={524-5}}"}}, {"_id": "24112969", "pmid": 24112969, "title": "Raynaud's phenomenon (primary).", "journal": "BMJ Clin Evid", "authors": ["Pope J"], "date": "2013-10-10T00:00:00Z", "meta_date_publication": "2013 Oct 10", "meta_volume": "2013", "meta_issue": "", "meta_pages": "1119", "score": 50077.223, "text_hl": "@<m>DISEASE_Raynaud_Disease</m> @DISEASE_MESH:D011928 @@@Raynaud's phenomenon@@@ (primary).", "citations": {"NLM": "Pope J. Raynaud's phenomenon (primary). BMJ Clin Evid. 2013 Oct 10;2013():1119. PMID: 24112969", "BibTeX": "@article{24112969, title={Raynaud's phenomenon (primary).}, author={Pope J}, journal={BMJ Clin Evid}, volume={2013}, pages={1119}}"}}, {"_id": "21401971", "pmid": 21401971, "title": "Raynaud's phenomenon (primary).", "journal": "BMJ Clin Evid", "authors": ["Pope JE"], "date": "2011-03-14T00:00:00Z", "meta_date_publication": "2011 Mar 14", "meta_volume": "2011", "meta_issue": "", "meta_pages": "", "score": 50077.15, "text_hl": "@<m>DISEASE_Raynaud_Disease</m> @DISEASE_MESH:D011928 @@@Raynaud's phenomenon@@@ (primary).", "citations": {"NLM": "Pope JE. Raynaud's phenomenon (primary). BMJ Clin Evid. 2011 Mar 14;2011():. PMID: 21401971", "BibTeX": "@article{21401971, title={Raynaud's phenomenon (primary).}, author={Pope JE}, journal={BMJ Clin Evid}, volume={2011}}"}}, {"_id": "19445785", "pmid": 19445785, "title": "Raynaud's phenomenon (primary).", "journal": "BMJ Clin Evid", "authors": ["Pope JE"], "date": "2008-12-16T00:00:00Z", "meta_date_publication": "2008 Dec 16", "meta_volume": "2008", "meta_issue": "", "meta_pages": "", "score": 50076.72, "text_hl": "@<m>DISEASE_Raynaud_Disease</m> @DISEASE_MESH:D011928 @@@Raynaud's phenomenon@@@ (primary).", "citations": {"NLM": "Pope JE. Raynaud's phenomenon (primary). BMJ Clin Evid. 2008 Dec 16;2008():. PMID: 19445785", "BibTeX": "@article{19445785, title={Raynaud's phenomenon (primary).}, author={Pope JE}, journal={BMJ Clin Evid}, volume={2008}}"}}, {"_id": "9812220", "pmid": 9812220, "title": "Rational use of calcium-channel antagonists in Raynaud's phenomenon.", "journal": "Curr Opin Rheumatol", "authors": ["Sturgill MG", "Seibold JR"], "date": "1998-11-01T00:00:00Z", "doi": "10.1097/00002281-199811000-00013", "meta_date_publication": "1998 Nov", "meta_volume": "10", "meta_issue": "6", "meta_pages": "584-8", "score": 50070.24, "text_hl": "The newer second-generation @CHEMICAL_Dihydropyridines @CHEMICAL_MESH:D004095 @@@dihydropyridines@@@ such as @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@, @CHEMICAL_Isradipine @CHEMICAL_MESH:D017275 @@@isradipine@@@, @CHEMICAL_Nicardipine @CHEMICAL_MESH:D009529 @@@nicardipine@@@, and @CHEMICAL_Felodipine @CHEMICAL_MESH:D015736 @@@felodipine@@@ also appear to be effective in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Raynaud_Disease</m> @DISEASE_MESH:D011928 @@@RP@@@ and may be associated with fewer adverse effects.", "citations": {"NLM": "Sturgill MG, Seibold JR. Rational use of calcium-channel antagonists in Raynaud's phenomenon. Curr Opin Rheumatol. 1998 Nov;10(6):584-8. PMID: 9812220", "BibTeX": "@article{9812220, title={Rational use of calcium-channel antagonists in Raynaud's phenomenon.}, author={Sturgill MG and Seibold JR}, journal={Curr Opin Rheumatol}, volume={10}, number={6}, pages={584-8}}"}}, {"_id": "24352340", "pmid": 24352340, "title": "Head-to-head comparison of udenafil vs amlodipine in the treatment of secondary Raynaud's phenomenon: a double-blind, randomized, cross-over study.", "journal": "Rheumatology (Oxford)", "authors": ["Lee EY", "Park JK", "Lee W", "Kim YK", "Park CS", "Giles JT", "Park JW", "Shin K", "Lee JS", "Song YW", "Lee EB"], "date": "2014-04-01T00:00:00Z", "doi": "10.1093/rheumatology/ket417", "meta_date_publication": "2014 Apr", "meta_volume": "53", "meta_issue": "4", "meta_pages": "658-64", "score": 50069.36, "text_hl": "Head-to-head comparison of @CHEMICAL_udenafil @CHEMICAL_MESH:C419664 @@@udenafil@@@ vs @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ in the treatment of secondary @<m>DISEASE_Raynaud_Disease</m> @DISEASE_MESH:D011928 @@@Raynaud's phenomenon@@@: a double-blind, randomized, cross-over study.", "citations": {"NLM": "Lee EY, Park JK, Lee W, Kim YK, Park CS, Giles JT, Park JW, Shin K, Lee JS, Song YW, Lee EB. Head-to-head comparison of udenafil vs amlodipine in the treatment of secondary Raynaud's phenomenon: a double-blind, randomized, cross-over study. Rheumatology (Oxford). 2014 Apr;53(4):658-64. PMID: 24352340", "BibTeX": "@article{24352340, title={Head-to-head comparison of udenafil vs amlodipine in the treatment of secondary Raynaud's phenomenon: a double-blind, randomized, cross-over study.}, author={Lee EY and Park JK and Lee W and Kim YK and Park CS and Giles JT and Park JW and Shin K and Lee JS and Song YW and Lee EB}, journal={Rheumatology (Oxford)}, volume={53}, number={4}, pages={658-64}}"}}, {"_id": "30915191", "pmid": 30915191, "title": "DHE-Induced Peripheral Arterial Vasospasm in Primary Raynaud Phenomenon: Case Report.", "journal": "Neurohospitalist", "authors": ["Khalife J", "Lauritsen CG", "Liang J", "Shah SO"], "date": "2019-04-01T00:00:00Z", "doi": "10.1177/1941874418797764", "meta_date_publication": "2019 Apr", "meta_volume": "9", "meta_issue": "2", "meta_pages": "113-115", "score": 50056.94, "text_hl": "Risk may be increased in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Raynaud_Disease</m> @DISEASE_MESH:D011928 @@@primary Raynaud phenomenon@@@. ", "citations": {"NLM": "Khalife J, Lauritsen CG, Liang J, Shah SO. DHE-Induced Peripheral Arterial Vasospasm in Primary Raynaud Phenomenon: Case Report. Neurohospitalist. 2019 Apr;9(2):113-115. PMID: 30915191", "BibTeX": "@article{30915191, title={DHE-Induced Peripheral Arterial Vasospasm in Primary Raynaud Phenomenon: Case Report.}, author={Khalife J and Lauritsen CG and Liang J and Shah SO}, journal={Neurohospitalist}, volume={9}, number={2}, pages={113-115}}"}}]}